Niagen Bioscience (NAGE) Return on Assets (2011 - 2026)
Niagen Bioscience (NAGE) reported Return on Assets of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and down 0.64% quarter-over-quarter from 0.0% in Q4 2025.
Niagen Bioscience (NAGE) Return on Assets (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets declined to 0.0% in Q1 2026 per NAGE's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q3 2025 and troughed at 0.01% in Q2 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
- On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then surged by 75 bps to 0.0% in 2023, then jumped by 248 bps to 0.0% in 2024, then gained by 24 bps to 0.0% in 2025, then dropped by 1 bps to 0.0% in 2026.
- Business Quant data shows NAGE's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -0.01% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.01% |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2020 | -0.01% |